About this trial
The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives.
Participants will:
* Complete a baseline survey * Receive access to web-based educational resources * Complete a brief follow up survey immediately after exploring these web-based resources * Complete a follow-up survey 3 months after enrolling
The investigators will compare outcomes among participants provided with access to a new website (intervention) summarizing recent patient-centered outcomes research (PCOR) comparing interval laparoscopic tubal sterilization and long-acting reversible contraception (LARC) to control participants provided with access to the existing Planned Parenthood website on tubal sterilization.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Self-reported fertility
Have a strong desire to avoid future pregnancy
Speak English or Spanish
Disqualifiers
Current pregnancy
The inability to speak English or Spanish
Prior tubal sterilization or "Essure" procedure
Menopause
Trial design
Parallel
Treatments tested in this trial
Control arm: Existing educational website
BehavioralInformation about tubal sterilization currently provided on the Planned Parenthood website
Advancing Access Website
BehavioralA website comparing tubal sterilization to long-acting reversible contraceptives informed by recent patient centered outcomes research.
Treatment groups
Trial outcomes
Primary outcomes
Perceived Access to Long Acting Contraceptives
A 9-item, multi-dimensional measure assessing awareness, availability, accessibility, affordability, and acceptability of contraceptive options including tubal sterilization, vasectomy, the subdermal implant, hormonal intrauterine device, and hormone-free intrauterine device. A summative score ranging from 0 to 48 points will be calculated for each participant at baseline and follow up. Investigators hypothesize there will be greater improvements from baseline to follow up in the intervention than control arm.
Secondary outcomes
Person-Centered Contraceptive Counseling Measure
4-items including: Letting me say what mattered to me about my birth control, Taking my preferences about my birth control seriously, Giving me enough information to make the best decision about my birth control method, Respecting me as a person, with responses range from 1 ("Strongly Disagree") to 5 ("Strongly Agree"). Investigators hypothesize there will be greater improvements from baseline in the intervention than control arm.
Consumer Assessment of Healthcare Providers and Systems
Response options on a 10-point Likert scale, ranging from poor (0) to excellent (10). Investigators hypothesize there will be greater improvements from baseline in the intervention than control arm.
Patients' Perceived Efficacy in Patient-Physician Interactions (PEPPI)
To create a score on the 5 item contraceptive "PEPPI scale" ranging from 5 (lowest possible score) to 25 (representing highest patient-perceived self-efficacy), each item begins with "How confident are participants in their ability to… ", and subjects respond to each question on a scale of 1 to 5, with 5 representing "very confident," and 1 representing "not at all confident" Investigators hypothesize there will be greater improvements from baseline to follow up in the intervention than control arm.
Knowledge of Long-Acting Contraceptives
10 items adapted from the previously used Tubal Sterilization Knowledge Questionnaire items developed by Hall et al. Answers will be coded as correct vs. incorrect (with "Don't Know" being coded as an incorrect response) to create a knowledge score. Investigators will calculate change in knowledge scores on follow up surveys compared to baseline. Investigators hypothesize there will be greater improvements from baseline in the intervention than control arm.
Other outcomes
Suggestions for how to improve web-based resources for people considering permanent contraception.
Open-ended question regarding ease-of-use and helpfulness of the web-based program. These responses will provide ongoing information to help guide future adaptations and dissemination.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, San Francisco
Lead sponsor
Essential Access Health
Collaborator
Agency for Healthcare Research and Quality (AHRQ)
Collaborator